Your browser doesn't support javascript.
loading
Dynamic Hyperinflation While Exercising-A Potential Predictor of Pulmonary Deterioration in Cystic Fibrosis.
Shmueli, Einat; Gendler, Yulia; Stafler, Patrick; Levine, Hagit; Steuer, Guy; Bar-On, Ophir; Blau, Hannah; Prais, Dario; Mei-Zahav, Meir.
Afiliación
  • Shmueli E; Graub Cystic Fibrosis Center, Pulmonary Institute, Schneider Children's Medical Center of Israel, 14 Kaplan Street, Petah Tiqwa 49202, Israel.
  • Gendler Y; Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
  • Stafler P; Department of Nursing, School of Health Sciences, Ariel University, Ariel 40700, Israel.
  • Levine H; Graub Cystic Fibrosis Center, Pulmonary Institute, Schneider Children's Medical Center of Israel, 14 Kaplan Street, Petah Tiqwa 49202, Israel.
  • Steuer G; Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
  • Bar-On O; Graub Cystic Fibrosis Center, Pulmonary Institute, Schneider Children's Medical Center of Israel, 14 Kaplan Street, Petah Tiqwa 49202, Israel.
  • Blau H; Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
  • Prais D; Graub Cystic Fibrosis Center, Pulmonary Institute, Schneider Children's Medical Center of Israel, 14 Kaplan Street, Petah Tiqwa 49202, Israel.
  • Mei-Zahav M; Graub Cystic Fibrosis Center, Pulmonary Institute, Schneider Children's Medical Center of Israel, 14 Kaplan Street, Petah Tiqwa 49202, Israel.
J Clin Med ; 12(18)2023 Sep 08.
Article en En | MEDLINE | ID: mdl-37762775
BACKGROUND: Lung function deterioration in cystic fibrosis (CF) is typically measured by a decline in the forced expiratory volume in one second (FEV1%), which is thought to be a late marker of lung disease. Dynamic hyperinflation (DH) is seen in obstructive lung diseases while exercising. Our aim was to assess whether DH could predict pulmonary deterioration in CF; a secondary measure was the peak VO2. METHODS: A retrospective study was conducted of people with CF who performed cardiopulmonary exercise tests (CPETs) during 2012-2018. The tests were classified as those demonstrating DH non-DH. Demographic, genetic, and clinical data until 12.2022 were extracted from patient charts. RESULTS: A total of 33 patients aged 10-61 years performed 41 valid CPETs with valid DH measurements; sixteen (39%) demonstrated DH. At the time of the CPETs, there was no difference in the FEV1% measurements between the DH and non-DH groups (median 83.5% vs. 87.6%, respectively; p = 0.174). The FEV1% trend over 4 years showed a decline in the DH group compared to the non-DH group (p = 0.009). A correlation was found between DH and the lung clearance index (LCI), as well as the FEV1% (r = 0.36 and p = 0.019 and r = -0.55 and p = 0.004, respectively). Intravenous (IV) antibiotic courses during the 4 years after the CPETs were significantly more frequent in the DH group (p = 0.046). The peak VO2 also correlated with the FEV1% and LCI (r = 0.36 and p = 0.02 and r = -0.46 and p = 0.014, respectively) as well as with the IV antibiotic courses (r = -0.46 and p = 0.014). CONCLUSIONS: In our cohort, the DH and peak VO2 were both associated with lung function deterioration and more frequent pulmonary exacerbations. DH may serve as a marker to predict pulmonary deterioration in people with CF.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article